In general, he added, patients who have diabetes have an underlying pancreatic dysfunction, so that is huge confounding bias as to why they may develop pancreatic disease. In yet another poster presentation at the meeting, Fernando Gil Lpez, also of Mayo Clinic, and colleagues conducted a systematic review and meta-analysis involving 16 studies, and a pooled total of more than 6 million patients in routine clinical settings, showing no significant increase in the risk for acute pancreatitis among those who were and were not treated with GLP-1 RAs (adjusted hazard ratio, 1.11)
In summary, the regulation of the AMPK and PPAR pathways via nanodelivery systems offers a promising therapeutic strategy for NAFLD, effectively improving liver steatosis, inflammation, and insulin resistance
80 (1): 110 Pessotto P, Valeri P, Arrigoni-Martelli E
So while a prescription from a licensed healthcare provider is required, that doesnt always mean the medication will be covered
Epub 2010 Oct 28
